|
Device
|
Applicant
|
PMA Number
|
Decision Date
|
COBAS® AMPLIPREP/COBAS® TAQMAN® CMV TEST (CAP/CTM ...
|
Roche Molecular Systems, Inc. |
P110037 |
07/05/2012 |
COBAS AMPLIPREP/COBAS TAQMAN CMV TEST
|
Roche Molecular Systems, Inc. |
P110037 S001 |
09/05/2012 |
COBAS AMPLIPREP/COBAS TAQMAN CMV TEST
|
Roche Molecular Systems, Inc. |
P110037 S002 |
09/14/2012 |
COBAS AMPLIPREP / COBAS TAQMAN CMV TEST, V2.0
|
Roche Molecular Systems, Inc. |
P110037 S003 |
01/07/2013 |
COBAS AMPLIPREP / COBAS TAQMAN CMV TEST
|
Roche Molecular Systems, Inc. |
P110037 S004 |
02/11/2013 |
COBAS AMPLIPREP/COBAS TAQMAN CYTOMEGALOVIRUS TEST
|
Roche Molecular Systems, Inc. |
P110037 S005 |
03/21/2013 |
COBAS AMPLIPREP/COBRA TAQMAN CMV TEST
|
Roche Molecular Systems, Inc. |
P110037 S006 |
06/06/2013 |
COBAS AMPLIPREP/CONAS TAQMAN CMV TEST
|
Roche Molecular Systems, Inc. |
P110037 S007 |
08/21/2013 |
COBAS AMPLIPREP/COBAS TAQMAN CMV TEST
|
Roche Molecular Systems, Inc. |
P110037 S008 |
09/06/2013 |
COBAS AMPLIPREP/COBAS TAQMAN CMV TEST
|
Roche Molecular Systems, Inc. |
P110037 S009 |
09/12/2013 |